This site is intended for healthcare professionals
Drug news

Positive phase III POLO trial of Lynparza in germline BRCA-mutated metastatic pancreatic cancer. AstraZeneca + Merck Inc.

Read time: 1 mins
Last updated:27th Feb 2019
Published:27th Feb 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest